novo nordisk semaglutide fda wins approval for higher-dose Ozempic for adults with type 2 diabetes The U.S. Food and Drug

Clinical Trial Results: The Numbers That Matter The Phase 2 clinical trial published in the New England Journal of Medicine provided the foundational data driving interest in Retatrutide

Epigenetic clock for skin and blood cells applied to Hutchinson Gilford progeria syndrome and ex vivo studies

This makes it a valuable option for those who are struggling with being overweight or obese, especially when traditional weight loss methods like diet and exercise alone are not sufficient

When Early Dosing May Be Appropriateand When It Isn't Taking your shot a day early is sometimes necessary due to travel, work schedules, or provider-approved adjustments

Contact your GP or prescribing clinician if uncertain about missed doses or experiencing severe abdominal pain, persistent vomiting, or signs of allergic reaction

North Carolina eliminated GLP-1 coverage beginning October 2025 due to a budget stalemate in the legislature, but coverage was reinstated in December 2025, bringing the total number of states covering GLP-1s for obesity to 13 as of January 2026